T Cell Responses to Human Endogenous Retroviruses in HIV-1 Infection
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Human endogenous retroviruses (HERVs) are remnants of ancient infectious agents that have integrated into the human genome. Under normal circumstances, HERVs are functionally defective or controlled by host factors. In HIV-1-infected individuals, intracellular defense mechanisms are compromised. We hypothesized that HIV-1 infection would remove or alter controls on HERV activity. Expression of HERV could potentially stimulate a T cell response to HERV antigens, and in regions of HIV-1/HERV similarity, these T cells could be cross-reactive. We determined that the levels of HERV production in HIV-1-positive individuals exceed those of HIV-1-negative controls. To investigate the impact of HERV activity on specific immunity, we examined T cell responses to HERV peptides in 29 HIV-1-positive and 13 HIV-1-negative study participants. We report T cell responses to peptides derived from regions of HERV detected by ELISPOT analysis in the HIV-1-positive study participants. We show an inverse correlation between anti-HERV T cell responses and HIV-1 plasma viral load. In HIV-1-positive individuals, we demonstrate that HERV-specific T cells are capable of killing cells presenting their cognate peptide. These data indicate that HIV-1 infection leads to HERV expression and stimulation of a HERV-specific CD8+ T cell response. HERV-specific CD8+ T cells have characteristics consistent with an important role in the response to HIV-1 infection: a phenotype similar to that of T cells responding to an effectively controlled virus (cytomegalovirus), an inverse correlation with HIV-1 plasma viral load, and the ability to lyse cells presenting their target peptide. These characteristics suggest that elicitation of anti-HERV-specific immune responses is a novel approach to immunotherapeutic vaccination. As endogenous retroviral sequences are fixed in the human genome, they provide a stable target, and HERV-specific T cells could recognize a cell infected by any HIV-1 viral variant. HERV-specific immunity is an important new avenue for investigation in HIV-1 pathogenesis and vaccine design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 HERV/HIV-1 Amino Acid Alignments Alignments were anchored based on short regions of similarity identified with BLAST [38] short nearly exact match search settings, which included both amino acid similarity estimated with evolutionary matrices (not shown in this figure) and identity. (A) HIV-1 HXB-2 and HERV-K (gi|5802821) showing a segment of the RT protein. Sequence numbering shown is based on position within individual accessions. Identical amino acids are shown in bold. (B) Short regions of similarity between reading frames within different HERV insertions [17,18] in the human genome and HIV-1 HXB-2 and their correspondence to regions of HIV-1. NT is shown when the region in HIV-1 was not a known CD8+ T cell epitope and the HIV-1 peptide was not included in the study.](https://figures.cochat.ai/paper-figures/5930593821084725860fa8d7e9c5d0ed/t-cell-responses-to-human-endogenous-retroviruses-in-hiv-1-infection-figure-2.jpg)





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is also clear, however, that endogenous retroviral antigens do not cause complete immunological tolerance and both T and B cell responses are frequently detected in both mice and humans 33,34,36–41.”
From Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis (2013) · cites this paper as [41]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302 · cited 2×
“Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.”
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
CD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717 · cited 1×
“activation level of a T cell [34].”
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978 · cited 1×
“However, chronic viral infections can lead to dysregulation of the CD8þ T cell response [36].”
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M. A., Papagno, L., Ogg, G. S., King, A., Lechner, F., Spina, C. A., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-379 · Cited by 1,571 · cited 2×
“Previous studies of T cells in chronic viral infections of humans have identified differences of phenotype and function between virus-specific CD8þ T cells, which have led to the notion that HIV-1-specific CD8þ T cells are deficient in their maturation, and potentially in function [ 31 ,32].”
BackgroundResultJin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,407
Parker, K. C., Bednarek, M. A., & Coligan, J. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.1.163 · Cited by 1,370 · cited 2×
“We manufactured peptides to test for T cell reactivity, based upon the analysis of HERV sequence with epitope prediction programs [20,21] and based on similarity to known CD8þT cell epitopes in HIV-1 [19].”
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K., Gumbs, C., Castagna, A., Cossarizza, A., et al. (2007) · Science · doi:10.1126/science.1143767 · Cited by 1,235 · cited 1×
“Interestingly, the HERV-L IQ10 peptide originates from an open reading frame in the same region (within 31 kbp) of another HERV-L insertion containing a polymorphism associated with improved control of HIV-1 viral load set point [29,30].”
MECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSING
Pamer, E., & Cresswell, P. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.323 · Cited by 1,008 · cited 1×
“peptides on the surface of infected cells [13].”
Research works printed but not linked: 1
- CoffinJMHughesSHVarmusHE 1997 Retroviruses Cold Spring Harbor (New York) Cold Spring Harbor Laboratory Press
Cited by
Jones, R. B., Ndhlovu, L. C., Barbour, J. D., Sheth, P. M., Jha, A. R., Long, B. R., Wong, J. C., Satkunarajah, M., Schweneker, M., Chapman, J. M., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081398 · Cited by 753
Self-citationEffects of Retroviruses on Host Genome Function
Jern, P., & Coffin, J. M. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.42.110807.091501 · Cited by 499
Douville, R., Liu, J., Rothstein, J., & Nath, A. (2011) · Annals of Neurology · doi:10.1002/ana.22149 · Cited by 317
“It is possible that systemic diseases, by virtue of generalized immune dysfunction, may lead to nonspecific activation of HERV transcripts, as has been shown following macrophage activation(25) and in patients with HIV infection.(32) Because the brain samples were obtained from different brain banks, the possibility t…”
BackgroundHERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency
Santoni, F. A., Guerra, J., & Luban, J. (2012) · Retrovirology · doi:10.1186/1742-4690-9-111 · Cited by 219
“Interestingly, HERVs can be activated by exogenous retrovirus infection [15] and, in reciprocal fashion, the immune response to these elements can influence the outcome of infection by pathogenic, exogenous retroviruses such as HIV-1 [16,17].”
BackgroundContreras-Galindo, R., Kaplan, M. H., Leissner, P., Verjat, T., Ferlenghi, I., Bagnoli, F., Giusti, F., Dosik, M. H., Hayes, D. F., Gitlin, S. D., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00646-08 · Cited by 213
“has now been confirmed by at least two other groups (26, 32).”
Human Endogenous Retrovirus K Triggers an Antigen-Specific Immune Response in Breast Cancer Patients
Wang-Johanning, F., Radvanyi, L., Rycaj, K., Plummer, J. B., Yan, P., Sastry, K. J., Piyathilake, C. J., Hunt, K. K., & Johanning, G. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6838 · Cited by 210
“A recent study in HIV-infected individuals found that the expression of endogenous HERV-K env is induced during HIV infection (14).”
Human endogenous retrovirus-K (HML-2): a comprehensive review
Garcia-Montojo, M., Doucet-O’Hare, T., Henderson, L., & Nath, A. (2018) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2018.1501345 · Cited by 210
“Similarly, several groups have reported T cell responses to HML-2 in HIV-infected patients (Garrison et al. 2007; SenGupta et al. 2011; Tandon et al. 2011; Jones et al. 2012) that are associated with better virologic control (Garrison et al. 2007; SenGupta et al. 2011) and higher T cell counts…”
BackgroundInfluentialBendall, M. L., de Mulder, M., Iñiguez, L. P., Lecanda-Sánchez, A., Pérez-Losada, M., Ostrowski, M. A., Jones, R. B., Mulder, L. C. F., Reyes-Terán, G., Crandall, K. A., et al. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006453 · Cited by 193
Self-citationHohn, O., Hanke, K., & Bannert, N. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00246 · Cited by 196
“HERV-K specific CD8+ T-cells that can recognize and kill cells presenting the cognate peptides as a result of HIVinduced expression of HERV proteins (119) may play an important part in the natural immune response to HIV (121).”
BackgroundJones, R. B., Mueller, S., O’Connor, R., Rimpel, K., Sloan, D. D., Karel, D., Wong, H. C., Jeng, E. K., Thomas, A. S., Whitney, J. B., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005545 · Cited by 160
“[27,28].”
Self-citationHuman RNA “Rumor” Viruses: the Search for Novel Human Retroviruses in Chronic Disease
Voisset, C., Weiss, R. A., & Griffiths, D. J. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00033-07 · Cited by 157
“While it is true that some individuals (with and without disease) do have T cells and antibodies that recognize HERV proteins (24, 60, 159, 208, 404), currently, no HERV protein is a recognized autoantigen in any disease.”
BackgroundVaccine Design for CD8 T Lymphocyte ResponsesPreprint
Koup, R. A., & Douek, D. C. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007252 · Cited by 136
“Evidence suggests that transcriptional control of human endogenous retroviruses (HERV) is compromised in HIV infection, leading to protein production and the induction of T-cell responses to endogenous retroviral antigens (Garrison et al. 2007).”
BackgroundHIV infection and HERV expression: a review
van der Kuyl, A. C. (2012) · Retrovirology · doi:10.1186/1742-4690-9-6 · Cited by 129
“[41], SenGupta et al.”
BackgroundInfluentialState-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations
Pauwels, K., Gijsbers, R., Toelen, J., Schambach, A., Willard-Gallo, K., Verheust, C., Debyser, Z., & Herman, P. (2009) · Current Gene Therapy · doi:10.2174/156652309790031120 · Cited by 106
“Moreover, RNA derived from HERVs is detectable in the plasma of HIV-1-infected individuals [106-108] supporting the view that significant protein coding capacity and activity potential still exist for these endogenous retroviruses [109, 110].”
BackgroundExpression of Human Endogenous Retrovirus Type K (HML-2) Is Activated by the Tat Protein of HIV-1
Gonzalez-Hernandez, M. J., Swanson, M. D., Contreras-Galindo, R., Cookinham, S., King, S. R., Noel, R. J., Kaplan, M. H., & Markovitz, D. M. (2012) · Journal of Virology · doi:10.1128/jvi.07215-11 · Cited by 122
Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunity
Balada, E., Ordi‐Ros, J., & Vilardell‐Tarrés, M. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.622 · Cited by 122
“On the other hand, an inverse correlation between anti-HERV T-cell responses and HIV-1 plasma viral load has recently been found [73] in HIV-1-infected patients, which leads to the possibility that antiHERV-specific immune responses may represent a novel approach to immunotherapeutic vaccination against HIV-1.”
BackgroundHuman Endogenous Retrovirus K (HML-2) in Health and Disease
Xue, B., Sechi, L. A., & Kelvin, D. J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01690 · Cited by 126
Hahn, S., Ugurel, S., Hanschmann, K.-M., Strobel, H., Tondera, C., Schadendorf, D., Löwer, J., & Löwer, R. (2008) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0286 · Cited by 108
“The fact that HERV-K proteins, which in principle are intrinsic self-antigens, can induce humoral and even cytotoxic T lymphocyte responses 24,25 is a promising indication that such approaches might be successful.”
AIDS Alters the Commensal Plasma Virome
Li, L., Deng, X., Linsuwanon, P., Bangsberg, D. R., Bwana, M., Hunt, P., Martin, J. N., Deeks, S. G., & Delwart, E. (2013) · Journal of Virology · doi:10.1128/jvi.01839-13 · Cited by 109
“A significant increase of HERV-K RNA but not HERV-H RNA has been reported in the plasma of HIV-infected subjects (26, 27).”
BackgroundChristensen, T. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9214-y · Cited by 99
HIV-1 infection activates endogenous retroviral promoters regulating antiviral gene expression
Badarinarayan, S. S., Shcherbakova, I., Langer, S., Koepke, L., Preising, A., Hotter, D., Kirchhoff, F., Sparrer, K. M. J., Schotta, G., & Sauter, D. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa832 · Cited by 102
Grandi, N., & Tramontano, E. (2017) · Viruses · doi:10.3390/v9070162 · Cited by 104
“T cell cross-reactivity between HERV and HIV epitopes was tested in vitro, giving negative results [182].”
BackgroundHERV-K–specific T cells eliminate diverse HIV-1/2 and SIV primary isolates
Jones, R. B., Garrison, K. E., Mujib, S., Mihajlovic, V., Aidarus, N., Hunter, D. V., Martin, E., John, V. M., Zhan, W., Faruk, N. F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64560 · Cited by 91
“ELISPOT assays were performed as previously described (25).”
InfluentialSelf-citationBhardwaj, N., Maldarelli, F. M., Mellors, J. W., & Coffin, J. M. (2014) · Journal of Virology · doi:10.1128/jvi.01623-14 · Cited by 92
Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis
Young, G. R., Stoye, J. P., & Kassiotis, G. (2013) · BioEssays · doi:10.1002/bies.201300049 · Cited by 78
“It is also clear, however, that endogenous retroviral antigens do not cause complete immunological tolerance and both T and B cell responses are frequently detected in both mice and humans [33, 34, 36–41].”
BackgroundDetection of Human Endogenous Retrovirus K (HERV-K) Transcripts in Human Prostate Cancer Cell Lines
Agoni, L., Guha, C., & Lenz, J. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00180 · Cited by 87
Self-citationToufaily, C., Landry, S., Leib‐Mösch, C., Rassart, É., & Barbeau, B. (2011) · Viruses · doi:10.3390/v3112146 · Cited by 75
Vincendeau, M., Göttesdorfer, I., Schreml, J., Wetie, A. G. N., Mayer, J. M., Greenwood, A. D., Helfer, M., Kramer, S., Seifarth, W., Hadian, K., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0156-6 · Cited by 79
“Plasma of HIV-1 infected individuals has been reported to contain elevated levels of HERV-K (HML-2) RNA [38,42,43].”
BackgroundLi, S.-K., Leung, R. K., Guo, H., Wei, J., Wang, J.-H., Kwong, K.-S., Lee, S.-S., Zhang, C., & Tsui, S. K. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03690.x · Cited by 73
“Actually, HERV sequences comprise about 8% of the human genome [26,27].”
BackgroundLefebvre, G., Desfarges, S., Uyttebroeck, F., Muñoz, M., Beerenwinkel, N., Rougemont, J., Telenti, A., & Ciuffi, A. (2011) · Journal of Virology · doi:10.1128/jvi.00252-11 · Cited by 69
“, the regulatory activity or generation of translated products, needs further analysis (13).”
BackgroundRangel, S. C., da Silva, M. D., da Silva, A. L., Santos, J. M. B., Neves, L. M., Pedrosa, A., Monteiro, F. R., Trettel, C. D. S., Furtado, G. E., Barros, M. P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1057791 · Cited by 80
Magiorkinis, G., Belshaw, R., & Katzourakis, A. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0504 · Cited by 68
Immune Responses to Retroviruses
Sáez‐Cirión, A., & Manel, N. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052155 · Cited by 71
Monde, K., Contreras-Galindo, R., Kaplan, M. H., Markovitz, D. M., & Ono, A. (2012) · Journal of Virology · doi:10.1128/jvi.00301-12 · Cited by 68
“Similarly, T cell responses to HERV-K were observed in HIV-1infected patients but not in healthy donors (19, 49, 51).”
BackgroundHuman Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K–Related Sequences
Contreras-Galindo, R., Kaplan, M. H., Dube, D., Gonzalez-Hernandez, M. J., Chan, S., Meng, F., Dai, M., Omenn, G. S., Gitlin, S. D., & Markovitz, D. M. (2015) · Journal of Virology · doi:10.1128/jvi.00544-15 · Cited by 64
Expression of Human Endogenous Retrovirus-W Including Syncytin-1 in Cutaneous T-Cell Lymphoma
Maliniemi, P., Vincendeau, M., Mayer, J. M., Frank, O., Hahtola, S., Karenko, L., Carlsson, E., Mallet, F., Seifarth, W., Leib‐Mösch, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076281 · Cited by 65
“by various environmental conditions such as chemicals, radiation or exogenous viruses [30-33].”
BackgroundSenGupta, D., Tandon, R., Vieira, R. G. S., Ndhlovu, L. C., Lown-Hecht, R., Ormsby, C. E., Loh, L., Jones, R. B., Garrison, K. E., Martin, J. N., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00179-11 · Cited by 64
“We also previously reported that adults with early HIV-1 infection have detectable ex vivo CD8 T cell responses to HERV antigens and that these responses are absent in healthy subjects (12).”
BackgroundMethodResultSelf-citationKraus, B., Fischer, K., Büchner, S. M., Wels, W. S., Löwer, R., Sliva, K., & Schnierle, B. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072756 · Cited by 65
“In this case, cell-mediated immune responses directed against HERV-K correlated with control of HIV-1 viremia [21], [22].”
BackgroundHuman endogenous retroviruses in neurologic disease
Christensen, T. (2016) · APMIS · doi:10.1111/apm.12486 · Cited by 61
“shown in reports of induction of cross-reactive HIV/HERV-K epitope cytotoxic T lymphocyte (CTL) responses to HIV (80, 81), and of activation”
BackgroundSacha, J. B., Kim, I.-J., Chen, L., Ullah, J. H., Goodwin, D. A., Simmons, H. A., Schenkman, D. I., von Pelchrzim, F., Gifford, R. J., Nimityongskul, F. A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200079 · Cited by 64
Self-citationExpression of Human Endogenous Retrovirus env Genes in the Blood of Breast Cancer Patients
Rhyu, D.-W., Kang, Y., Ock, M., Eo, J., Choi, Y. H., Kim, W., Leem, S., Yi, J., Kim, H., & Cha, H. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069173 · Cited by 60
“Several reports have shown that HERVs are involved in several diseases including multiple sclerosis [7,8], schizophrenia [9], and HIV-infection [10].”
BackgroundBrinzevich, D., Young, G. R., Sebra, R., Ayllón, J., Maio, S. M., Deikus, G. Y., Chen, B. K., Fernández-Sesma, A., Simon, V. R., & Mulder, L. C. F. (2014) · Journal of Virology · doi:10.1128/jvi.00669-14 · Cited by 61
Young, G. R., Ploquin, M. J.-Y., Eksmond, U., Wadwa, M., Stoye, J. P., & Kassiotis, G. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002709 · Cited by 56
“Expression of human endogenous retroviruses, as well as CD8 T cell responses against their antigens, have been documented in HIV infection [57,58].”
BackgroundMichaud, H., Rougvie, M. D. M., SenGupta, D., Deeks, S. G., Martin, J. N., Pilcher, C. D., Hecht, F. M., Sacha, J. B., & Nixon, D. F. (2014) · Retrovirology · doi:10.1186/1742-4690-11-10 · Cited by 56
“We have shown that an anti-HERV-K (HML-2) cellular immune response is generated in HIV-1 infected patients (HIV), significantly increased in elite controllers, and HERV-K specific T-cell clones can eliminate HIV-1 infected cells in vitro [26,27,29].”
BackgroundSelf-citationHuman Endogenous Retrovirus-K(II) Envelope Induction Protects Neurons during HIV/AIDS
Bhat, R. K., Rudnick, W., Antony, J. M., Maingat, F. G., Ellestad, K. K., Wheatley, B. M., Tönjes, R. R., & Power, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097984 · Cited by 59
“Induction of HERV-K expression during HIV/AIDS is a recognized phenomenon in blood and appears to be associated with disease progression during HIV/AIDS [32,33,34].”
BackgroundHERV ‐K( HML ‐2), a seemingly silent subtenant – but still waters run deep
Hanke, K., Höhn, O., & Bannert, N. (2016) · Apmis · doi:10.1111/apm.12475 · Cited by 60
“demonstrated in some HIV-1-infected patients (201).”
Sherrill-Mix, S. A., Ocwieja, K. E., & Bushman, F. D. (2015) · Retrovirology · doi:10.1186/s12977-015-0205-1 · Cited by 54
Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity
Monde, K., Terasawa, H., Nakano, Y., Soheilian, F., Nagashima, K., Maeda, Y., & Ono, A. (2017) · Retrovirology · doi:10.1186/s12977-017-0351-8 · Cited by 52
Wallace, A. D., Wendt, G. A., Barcellos, L. F., de Smith, A. J., Walsh, K. M., Metayer, C., Costello, J., Wiemels, J. L., & Francis, S. S. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00298 · Cited by 50
“Previous studies have established links between HERV-K and amyotrophic lateral sclerosis (Alfahad and Nath, 2013), HIV-associated dementia (Garrison et al., 2007), and Schizophrenia (Sekar et al.”
ResultJha, A. R., Nixon, D. F., Rosenberg, M. G., Martin, J. N., Deeks, S. G., Hudson, R. R., Garrison, K. E., & Pillai, S. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020234 · Cited by 49
“In addition, HERVs have been implicated in playing a role in a number of diseases [6,7,8,9,10,11].”
BackgroundSelf-citationYoung, G. R., Terry, S. N., Manganaro, L., Cuesta‐Domínguez, Á., Deikus, G. Y., Bernal‐Rubio, D., Campisi, L., Fernández-Sesma, A., Sebra, R., Simon, V. R., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01507-17 · Cited by 44
Endogenous Retroviruses Drive Resistance and Promotion of Exogenous Retroviral Homologs
Chiu, E. S., & VandeWoude, S. (2020) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-050620-101416 · Cited by 53
HLA class I molecules reflect an altered host proteome after influenza virus infection
Wahl, A., Schafer, F. B., Bardet, W., & Hildebrand, W. H. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.08.012 · Cited by 41
“CTL reactive host HLA class I peptides have been demonstrated during HIV-1 and measles virus infection and in the case of HIV-1 these virus-associated host ligands are being explored as vaccine candidates (16,46).”
Kraus, B., Fischer, K., Sliva, K., & Schnierle, B. S. (2014) · Virology Journal · doi:10.1186/1743-422x-11-58 · Cited by 44
Human endogenous retroviruses and the nervous system
Douville, R. N., & Nath, A. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53488-0.00022-5 · Cited by 45
“Substantial homology in immunogenic viral peptides is shared between HERVs and exogenous retroviruses (Garrison et al., 2007; Thomas et al., 2010).”
BackgroundInfluentialJha, A. R., Pillai, S. K., York, V. A., Sharp, E. R., Storm, E. C., Wachter, D. J., Martin, J. N., Deeks, S. G., Rosenberg, M. G., Nixon, D. F., et al. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp180 · Cited by 47
“…al. 2008; Wang-Johanning et al. 2008), autoimmune diseases such as rheumatoid arthritis (Sicat et al. 2005; Ehlhardt et al. 2006), type 1 diabetes (Marguerat et al. 2004), schizophrenia (Otowa et al. 2006), and possibly also in HIV-1 infection (Contreras-Galindo et al. 2007; Garrison et al. 2007).”
BackgroundSelf-citationChen, X., & Li, D. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz205 · Cited by 41
Tandon, R., SenGupta, D., Ndhlovu, L. C., Vieira, R. G. S., Jones, R. B., York, V. A., Vieira, V., Sharp, E. R., WIZNIA, A. A., Ostrowski, M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05418-11 · Cited by 37
“Cryopreserved peripheral blood mononuclear cells (PBMC) from study participants were thawed and screened for responses against a set of 28 HERV peptides (10) using a gamma interferon (IFN- ) enzyme-linked immunosorbent spot (ELISPOT) assay (24, 23).”
BackgroundMethodSelf-citationPalma, P., Romiti, M. L., Montesano, C., Santilli, V., Mora, N., Aquilani, A., Dispinseri, S., Tchidjou, H. K., Montano, M. A. E., Eriksson, L. E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079957 · Cited by 35
“Gag specific T-cell responses have been shown to correlate with lower levels of viral load in chronically infected patients [4,25,26,27], and with a better prognosis [28,29].”
BackgroundBlaser, M. J., & Valentine, F. T. (2008) · The Journal of Infectious Diseases · doi:10.1086/588705 · Cited by 35
“Cytotoxic lymphocytes directed against peptides encoded by these retroviral genes can be detected in the blood of HIV-infected individuals [20].”
BackgroundHuman endogenous retrovirus and multiple sclerosis: A review and transcriptome findings
Nali, L. H. D. S., do Olival, G. S., Montenegro, H., da Silva, I. T., Dias‐Neto, E., Naya, H., Spangenberg, L., de Oliveira, A. C. P., & Romano, C. M. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103383 · Cited by 30
Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers
Rougvie, M. D. M., SenGupta, D., Deeks, S. G., Martin, J. N., Pilcher, C. D., Hecht, F. M., Sacha, J. B., Nixon, D. F., & Michaud, H. (2017) · Retrovirology · doi:10.1186/s12977-017-0365-2 · Cited by 28
Self-citationEndogenous Retrovirus-K and Nervous System Diseases
Manghera, M., Ferguson, J., & Douville, R. N. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0488-y · Cited by 29
Ormsby, C. E., SenGupta, D., Tandon, R., Deeks, S. G., Martin, J. N., Jones, R. B., Ostrowski, M., Garrison, K. E., Vázquez-Pérez, J. A., Reyes‐Terán, G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041021 · Cited by 28
“While HERV-K gag and env expression was present to a low degree in some HIV-1-negative subjects, the infected group had a significantly higher level of relative HERV-K expression, as expected and previously reported [31,38].”
BackgroundResultInfluentialSelf-citationThe potential role of retroviruses in autoimmunity
Yu, P. (2015) · Immunological Reviews · doi:10.1111/imr.12371 · Cited by 29
“Indirect evidence demonstrating increased antibody (36) or T-cell response (37) against HERVs was found and direct evidence of HERV-RNA upregulation (38).”
BackgroundMichaud, H., SenGupta, D., Rougvie, M. D. M., Deeks, S. G., Martin, J. N., Kobie, J. J., Sacha, J. B., & Nixon, D. F. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302108 · Cited by 24
“During HIV-1 infection, HERV-K mRNA transcripts and viral proteins can be detected in serum (6, 7).”
BackgroundSelf-citationHuman endogenous retroviruses and exogenous viral infections
Bao, C., Gao, Q., Xiang, H., Shen, Y., Chen, Q., Gao, Q., Cao, Y., Zhang, M., He, W., & Mao, L. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1439292 · Cited by 25
Structural basis for Fullerene geometry in a human endogenous retrovirus capsid
Acton, O., Grant, T., Nicastro, G., Ball, N. J., Goldstone, D. C., Robertson, L. E., Sader, K., Nans, A., Ramos, A., Stoye, J. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13786-y · Cited by 22
How Retroviruses Escape the Nonsense-Mediated mRNA Decay
Mocquet, V., Durand, S., & Jalinot, P. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0326 · Cited by 24
“120,121 Since we suggested previously that HIV-1 could favor the incorporation of UPF1 in specific complexes at the expense of those triggering NMD, those combined data might support the possibility that NMD could control the expression of endogenous retrovirus.”
Perivascular tissue resident memory T cells as therapeutic target in multiple sclerosis
Smolders, J., Fransen, N. L., Hsiao, C., Hamann, J., & Huitinga, I. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1776609 · Cited by 25
“Moreover expression of endogenous retrovirus sequences has been described in MS lesions[119], which may also elicit a CD8 T-cell response[120].”
BackgroundJones, A. R., Iacoangeli, A., Adey, B. N., Bowles, H., Shatunov, A., Troakes, C., Garson, J. A., McCormick, A., & Al‐Chalabi, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-93742-3 · Cited by 25
Agoni, L., Lenz, J., & Guha, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076472 · Cited by 24
“Most notably, immune responses have been observed against the most recently acquired set of retroviruses in the human genome, HERV-K [18,19,22,23].”
BackgroundSelf-citationTumorigenesis related to retroviral infections
Braoudaki, M., & Tzortzatou-Stathopoulou, F. F. (2011) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.1773 · Cited by 20
“Under normal circumstances, HERVs are functionally defective or controlled by host factors [9-11].”
BackgroundEvolutionary Medicine of Retroviruses in the Human Genome
Katsura, Y., & Asai, S. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.09.007 · Cited by 22
“38 Monde et al showed that gag proteins encoded by HERV-K changed the size and morphology of HIV particles, and these changes caused signi fi cant diminishing of the release ef fi ciency and infectivity of HIV viruses.”
Beyond pathogens: the intriguing genetic legacy of endogenous retroviruses in host physiology
da Silva, A. L., Guedes, B. L. M., Santos, S. N., Correa, G. F., Nardy, A., Nali, L. H. D. S., Bachi, A. L. L., & Romano, C. M. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1379962 · Cited by 19
Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy
Perzova, R., Graziano, E. J., Sanghi, S., Welch, C., Benz, P. M., Abbott, L. Z., Lalone, D., Glaser, J. B., Loughran, T. P., Sheremata, W. A., et al. (2013) · Virology Journal · doi:10.1186/1743-422x-10-360 · Cited by 19
Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques
Li, H., Nykoluk, M., Lin, L., Liu, L. R., Omange, R. W., Soule, G., Schroeder, L. T., Toledo, N., Kashem, M. A., Correia‐Pinto, J. F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186079 · Cited by 17
Curty, G., Beckerle, G. A., Iñiguez, L., O’Brien, R. L. F., de Carvalho, P. S., Marston, J. L., Champiat, S., Heymann, J. J., Ormsby, C. E., Reyes‐Terán, G., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.553983 · Cited by 17
“Interesting, we previously reported HERV-L specific immunity in HIV-1 infection, characterizing a potential novel target for assessment of HIV pathogenesis (27).”
BackgroundSelf-citationHu, X., Zhu, W., Chen, S., Liu, Y., Sun, Z., Geng, T., Song, C., Gao, B., Wang, X., Qin, A., et al. (2016) · Archives of Virology · doi:10.1007/s00705-016-3086-2 · Cited by 17
“Several studies have suggested that ERVs have a strong influence on T lymphocyte selection and improve the sensitivity with which T lymphocytes react to retroviral infection [11, 52, 54].”
BackgroundSokol, M., Jessen, K. M., & Pedersen, F. S. (2016) · Apmis · doi:10.1111/apm.12477 · Cited by 16
A polymorphism in the HCP5 gene associated with HLA-B*5701 does not restrict HIV-1 in vitro
Yoon, W., Ma, B.-J., Fellay, J., Huang, W., Xia, S.-M., Zhang, R., Shianna, K. V., Liao, H., Haynes, B. F., & Goldstein, D. B. (2009) · AIDS · doi:10.1097/qad.0b013e32833202f5 · Cited by 16
A contaminant-free assessment of Endogenous Retroviral RNA in human plasma
Karamitros, T., Paraskevis, D. N., Hatzakis, A. E., Psichοgiou, M., Elefsiniotis, I. S., Hurst, T. P., Geretti, A. M., Beloukas, A. I., Frater, J., Klenerman, P., et al. (2016) · Scientific Reports · doi:10.1038/srep33598 · Cited by 19
“In our study, we used DNase to remove gDNA contaminants in the post-extraction stage, as two other groups did, the first reporting relatively increased HK2 RNA levels in 16 HIV-positive versus 4 HIV-negative patients 30 , while the second reported no HK2 RNA in the plasma of HIV-1 patients 29 .”
Grandi, N., Pisano, M. P., Scognamiglio, S., Pessiu, E., & Tramontano, E. (2020) · Viruses · doi:10.3390/v12040481 · Cited by 16
Transactivation of Human Endogenous Retroviruses by Viruses
Evans, E., Saraph, A., & Tokuyama, M. (2024) · Viruses · doi:10.3390/v16111649 · Cited by 20
Jones, R. B., John, V. M., Hunter, D. V., Martin, E., Mujib, S., Mihajlovic, V., Burgers, P. C., Luider, T. M., Gyenes, G. T., Sheppard, N. C., et al. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05583-11 · Cited by 17
“Our original presentation of HERV-specific T-cell responses in HIV-1-infected subjects (12) used different batches of peptides (from a different manufacturer) than those used for our follow-up studies (25).”
BackgroundMethodSelf-citationLiu, T., Xing, Y., Fan, X., Chen, Z., Zhao, C., Liu, L., Zhao, M., Hu, X., Dong, B., Wang, J., et al. (2020) · Poultry Science · doi:10.1016/j.psj.2020.11.057 · Cited by 15
Jones, R. B., Leal, F. E., Hasenkrug, A. M., Segurado, A. A. C., Nixon, D. F., Ostrowski, M., & Kallas, E. G. (2013) · Journal of Negative Results in BioMedicine · doi:10.1186/1477-5751-12-3 · Cited by 14
“We did also screen these subjects for responses to peptides derived from diverse HERV families selected based on predicted binding to common MHC-I alleles, many of which have previously been demonstrated to be immunoreactive HIV-1-infected subjects [12-14].”
BackgroundMethodResultSelf-citationWu, H. L., León, E. J., Wallace, L. T., Nimiyongskul, F. A., Buechler, M. B., Newman, L. P., Castrovinci, P. A., Johnson, R. P., Gifford, R. J., Jones, R. B., et al. (2016) · Retrovirology · doi:10.1186/s12977-016-0238-0 · Cited by 14
“In addition, HERV-specific cellular and humoral immunity has been reported in humans, particularly in the context of exogenous retroviral infection with human immunodeficiency virus (HIV) [10–13].”
BackgroundSelf-citationZwolińska, K., Knysz, B., Gąsiorowski, J., Pazgan−Simon, M., Gładysz, A., Sobczyński, M., & Piasecki, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077820 · Cited by 16
“The confirmation of the impact of HIV on HERVs expression was the finding of humoral and cellular responses against the structural proteins of HERV-K in people with HIV [12,15,37].”
BackgroundInside the Envelope: Endogenous Retrovirus-K Env as a Biomarker and Therapeutic Target
Nadeau, M.-J., Manghera, M., & Douville, R. N. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01244 · Cited by 16
“However its use independently of co-indicators may be limited due to enhanced expression not only in cancers, but also in infectious and neurological diseases (Garrison et al., 2007; Li et al., 2015).”
BackgroundGarde, C., Pavlidis, M. A., Garces, P., Lange, E. J., Ramarathinam, S. H., Sokač, M., Pandey, K., Faridi, P., Ahrenfeldt, J., Chung, S., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01107-y · Cited by 12
“However, it has been docu-mentedthat,inpathologicalconditionssuchascancerandHIV-1infection, lossoftranscriptionalregulationeffectivelyleadstoupregulatedexpression ofEVEgenes 14,15 .”
Dou, A., Xu, J., & Zhou, C. (2025) · Virulence · doi:10.1080/21505594.2025.2523888 · Cited by 11
Locus-specific human endogenous retroviruses reveal lymphoma subtypes
Singh, B., Dopkins, N., Fei, T., Marston, J. L., Michael, S., Reyes-Gopar, H., Curty, G., Heymann, J. J., Chadburn, A., Martin, P., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112541 · Cited by 11
Self-citationInteractions between human immunodeficiency virus and human endogenous retroviruses
Li, M., Yu, F., Zhu, B., Jiang, X., Chang, Y., Yang, X., Liang, X., Wang, F., Zhang, H., & Zhang, F. (2025) · Journal of Virology · doi:10.1128/jvi.02319-24 · Cited by 12
“It has been reported that specific CD8 + T cell responses against HERVs (HERV-K/L/H/W) peptides can be detected in PLWHs (56).”
InfluentialMarsh, A. K., Willer, D. O., Skokovets, O., Iwajomo, O. H., Chan, J. K., & MacDonald, K. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040158 · Cited by 10
“cellular protein targets derived from HERV-K [3].”
BackgroundKaplan, M. H., Kaminski, M. S., Estes, J. M., Gitlin, S. D., Zahn, J., Elder, J. T., Tejasvi, T., Gensterblum‐Miller, E., Sawalha, A. H., McGowan, J. P., et al. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0505-8 · Cited by 11
Maness, N. J., Sacha, J. B., Piaskowski, S. M., Weisgrau, K. L., Rakasz, E. G., May, G. E., Buechler, M. B., Walsh, A. D., Wilson, N. A., & Watkins, D. I. (2009) · Journal of Virology · doi:10.1128/jvi.00138-09 · Cited by 10
Human Endogenous Retrovirus, SARS-CoV-2, and HIV Promote PAH via Inflammation and Growth Stimulation
Wang, D., Gomes, M. T., Mo, Y., Prohaska, C. C., Zhang, L., Chelvanambi, S., Clauss, M. A., Zhang, D., Machado, R. F., Gao, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087472 · Cited by 11
Sheppard, N. C., Jones, R. B., Burwitz, B. J., Nimityongskul, F. A., Newman, L. P., Buechler, M. B., Reed, J. S., Piaskowski, S. M., Weisgrau, K. L., Castrovinci, P. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092012 · Cited by 9
“both HIV infection [5] and cancer [59,60] have been identified”
BackgroundSelf-citationExpression of human endogenous retrovirus K and W in babies
Nali, L. H. D. S., Oliveira, A. C. S., Alves, D. O., Caleiro, G. S., Nunes, C. F., Gerhardt, D., Succi, R. C. M., Romano, C. M., & Machado, D. M. (2016) · Archives of Virology · doi:10.1007/s00705-016-3167-2 · Cited by 9
“In fact, there are many studies that describe HERVs activity in adults with or without HIV [9, 11, 15] and also suffering from other diseases [16–18].”
Background
Metadata
- Authors
- Garrison, K. E., Jones, R. B., Meiklejohn, D. A., Anwar, N., Ndhlovu, L. C., Chapman, J. M., Erickson, A. L., Agrawal, A., Spotts, G., Hecht, F. M., Rakoff-Nahoum, S., Lenz, J., Ostrowski, M. A., & Nixon, D. F.
- Affiliations
- University of California, San Francisco (US)
- University of Toronto (CA)
- Gladstone Institutes (US)
- San Francisco General Hospital (US)
- Yale University (US)
- Albert Einstein College of Medicine (US)
- St. Michael's Hospital (CA)
- Corresponding author
- Garrison, Keith E
- Jones, R. Brad
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-11-09
- Volume
- 3
- Issue
- 11
- Pages
- e165
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2065876
- OpenAlex
- W2157279932
- Cited by
- 131
- References
- 38
- Citations by year
- 2025: 8 · 2024: 6 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 6 · 2016: 11 · 2015: 6 · 2014: 12 · 2013: 13 · 2012: 10
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Faculty of Medical and Health Sciences, University of Auckland
- National Institute of Allergy and Infectious Diseases (R01AI076059)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- human endogenous retroviruses, HIV-1 infection, T cell response, immunological cross-reactivity, viral load, HERV expression, cytomegalovirus, HIV vaccine design
- MeSH terms
- Antigens, Viral, Cross-Sectional Studies, Flow Cytometry, Humans, RNA, Viral, Cohort Studies, HIV-1, HIV Infections, CD8-Positive T-Lymphocytes, Viral Load, Endogenous Retroviruses, Reverse Transcriptase Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.